NASDAQ:URGN

Urogen Pharma Stock Predictions

etoro logo Buy URGN
*Your capital is at risk
$26.60
+0.0600 (+0.226%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

URGN Prediction Chart

URGN Predictions History

Latest community submissions for URGN.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 10, 2026 $19.28 -3.17% $19.45 V 99.12% 3
Mar 10, 2026 $20.30 +1.98% $19.45 X 95.61% 0
Skagitqg Skagitqg Merchant
Mar 10, 2026 Bearish $19.45 V 1
Aug 6, 2025 $20.30 -2.01% $20.01 V 98.54% 2
Aug 6, 2025 $20.46 -1.26% $20.01 V 97.76% 1
Aug 6, 2025 $20.93 +1.01% $20.01 X 95.40% 0
Jun 13, 2025 $10.57 -4.63% $12.03 X 87.84% 0
Jun 13, 2025 $10.76 -2.89% $12.03 X 89.44% 0
Jun 13, 2025 Bullish $12.03 V 1
Jun 11, 2025 Bullish $7.30 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for URGN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT UROGEN PHARMA LTD
UroGen Pharma
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE